These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 34458211

  • 21. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women.
    Wassef H, Bissonnette S, Dufour R, Davignon J, Faraj M.
    J Nutr; 2017 May; 147(5):754-762. PubMed ID: 28356429
    [Abstract] [Full Text] [Related]

  • 22. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A, Hergenç G, Sansoy V, Fobker M, Ceyhan K, Toprak S, Assmann G.
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [Abstract] [Full Text] [Related]

  • 23. Changes in low-density lipoprotein size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventions.
    Mendoza S, Trenchevska O, King SM, Nelson RW, Nedelkov D, Krauss RM, Yassine HN.
    J Clin Lipidol; 2017 May; 11(1):224-233.e2. PubMed ID: 28391889
    [Abstract] [Full Text] [Related]

  • 24. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.
    Le NA, Gibson JC, Ginsberg HN.
    J Lipid Res; 1988 May; 29(5):669-77. PubMed ID: 3411241
    [Abstract] [Full Text] [Related]

  • 25. Role of 24-h ambulatory blood pressure monitoring in children with chronic kidney disease.
    Gupta D, Chaturvedi S, Chandy S, Agarwal I.
    Indian J Nephrol; 2015 May; 25(6):355-61. PubMed ID: 26664211
    [Abstract] [Full Text] [Related]

  • 26. Impact of bariatric surgery on apolipoprotein C-III levels and lipoprotein distribution in obese human subjects.
    Maraninchi M, Padilla N, Béliard S, Berthet B, Nogueira JP, Dupont-Roussel J, Mancini J, Bégu-Le Corroller A, Dubois N, Grangeot R, Mattei C, Monclar M, Calabrese A, Guérin C, Desmarchelier C, Nicolay A, Xiao C, Borel P, Lewis GF, Valéro R.
    J Clin Lipidol; 2017 May; 11(2):495-506.e3. PubMed ID: 28502507
    [Abstract] [Full Text] [Related]

  • 27. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.
    International Society for Chronobiology, American Association of Medical Chronobiology and Chronotherapeutics, Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk, Spanish Society of Atherosclerosis, Romanian Society of Internal Medicine, Hermida RC, Smolensky MH, Ayala DE, Portaluppi F.
    Chronobiol Int; 2013 Apr; 30(3):355-410. PubMed ID: 23517220
    [Abstract] [Full Text] [Related]

  • 28. Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.
    Qamar A, Khetarpal SA, Khera AV, Qasim A, Rader DJ, Reilly MP.
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1880-8. PubMed ID: 26069232
    [Abstract] [Full Text] [Related]

  • 29. Urinary arginine methylation index associated with ambulatory blood pressure abnormalities in children with chronic kidney disease.
    Kuo HC, Hsu CN, Huang CF, Lo MH, Chien SJ, Tain YL.
    J Am Soc Hypertens; 2012 Aug; 6(6):385-92. PubMed ID: 23107896
    [Abstract] [Full Text] [Related]

  • 30. A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease.
    Kei AA, Filippatos TD, Tsimihodimos V, Elisaf MS.
    Metabolism; 2012 Jul; 61(7):906-21. PubMed ID: 22304839
    [Abstract] [Full Text] [Related]

  • 31. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC, Ayala DE, Fernández JR, Mojón A.
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [Abstract] [Full Text] [Related]

  • 32. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C, Tremblay M, Fredenrich A, Davignon J, Cohn JS.
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Measurement and treatment of elevated blood pressure in the pediatric patient with chronic kidney disease.
    Swinford RD, Portman RJ.
    Adv Chronic Kidney Dis; 2004 Apr; 11(2):143-61. PubMed ID: 15216486
    [Abstract] [Full Text] [Related]

  • 37. Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.
    Cohn JS, Patterson BW, Uffelman KD, Davignon J, Steiner G.
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3949-55. PubMed ID: 15292332
    [Abstract] [Full Text] [Related]

  • 38. Postprandial distribution of apolipoproteins C-II and C-III in normal subjects and patients with mild hypertriglyceridemia: comparison of meals containing corn oil and medium-chain triglyceride oil.
    Barr SI, Kottke BA, Mao SJ.
    Metabolism; 1985 Nov; 34(11):983-92. PubMed ID: 4058312
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
    Attman PO, Alaupovic P.
    Nephron; 1991 Nov; 57(4):401-10. PubMed ID: 2046821
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.